Pfizer Limited (BOM:500680)

India flag India · Delayed Price · Currency is INR
4,982.50
+53.95 (1.09%)
At close: Dec 31, 2025
-5.56%
Market Cap224.89B
Revenue (ttm)23.75B
Net Income (ttm)8.39B
Shares Outn/a
EPS (ttm)183.47
PE Ratio26.79
Forward PE28.64
Dividend165.00 (3.27%)
Ex-Dividend DateJul 9, 2025
Volume1,370
Average Volume1,361
Open4,935.50
Previous Close4,928.55
Day's Range4,926.55 - 5,010.00
52-Week Range3,742.90 - 5,987.65
Betan/a
RSI37.99
Earnings DateFeb 13, 2026

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 1,598
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500680
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.

Financial Statements

News

Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands

Pfizer Limited on Thursday announced that it has entered into an exclusive supply and marketing agreement with Cipla for four...

14 days ago - Business Upturn

Pfizer shares jump over 5% as Q2 profit rises 19% YoY on strong operational performance

Shares of Pfizer Ltd surged 5.83% to Rs 5,308 on Thursday, November 13, after the company reported a solid set...

7 weeks ago - Business Upturn

Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY

Pfizer Ltd’s shares surged 5.4% to ₹5,385 in early trade on Thursday after the pharmaceutical company reported robust first-quarter results for FY26. The company’s net profit grew 27.2% year-on-year (...

5 months ago - Business Upturn

Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India

Shares of Pfizer Limited rose 2.07% to Rs 5,165.50 on Tuesday, August 12, following the company’s announcement of the launch of its next-generation 20-valent Pneumococcal Polysaccharide Conjugate Vacc...

5 months ago - Business Upturn